Aphthasol (amlexanox oral paste), the first Rx drug approved for aphthous ulcers

January 1998

Patients will be asking about Aphthasol (amlexanox oral paste), the first Rx drug approved for aphthous ulcers.

These ulcers are thought to be caused by an autoimmune reaction...not by herpes, like fever blisters or cold sores.

Aphthasol reduces inflammation and allergic reactions...probably by inhibiting histamines, leukotrienes, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Evista (raloxifene), the new designer estrogen
Interactions Significant interaction between Buspar (buspirone) and erythromycin or itraconazole (Sporanox)
Interactions New drug interactions and warnings are also being reported for Posicor (mibefradil)
Cholesterol Zocor (simvastatin) is now approved to lower triglycerides
Cholesterol Baycol (cerivastatin) from Bayer
Cholesterol Switch from one statin to another
Oral Health Aphthasol (amlexanox oral paste), the first Rx drug approved for aphthous ulcers
Oral Health Colgate Total
Diabetes More frequent liver function tests for diabetics taking Rezulin (troglitazone)
Diabetes Monitor long-term blood sugar control at home
Milk thistle for hepatotoxicity
Migraine Zomig (zolmitriptan) for migraines
Migraine Migranal, a new Nasal Spray for migraines
Migraine Stadol is now a federally controlled substance (C-IV)
Two new dry powder inhalers will soon hit the market
Hematology & Oncology The first monoclonal antibody for cancer
Hair Loss Two new treatments for male-pattern hair loss
Practice Annual chart of new drugs for 1997